A Retrospective Analysis Of Nanoparticle Albumin Bound Paclitaxel In Chinese Patients With Recurrent Advanced Non-small Cell Lung Cancer In A Single Center

被引：0
|
作者：
Zhu, Yixiang [1 ,2 ]
Xing, Puyuan [1 ,2 ]
Chen, Sipeng [3 ]
Li, Junling [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
nanoparticle albumin bound paclitaxel (Nab-PTX); advanced non-small cell lung cancer; chemotherapy;
D O I：
10.1016/j.jtho.2016.11.1228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-019
引用
收藏
页码：S899 / S900
页数：2
相关论文
共 50 条
  • [1] Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study
    Liu, Yang
    Dong, Yinping
    Zhu, Hui
    Jing, Wang
    Guo, Hongbo
    Yu, Jinming
    [J]. CANCER MEDICINE, 2020, 9 (04): : 1365 - 1373
  • [2] Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence
    Herrera, Diego Adrianzen
    Ashai, Nadia
    Perez-Soler, Roman
    Cheng, Haiying
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (01) : 95 - 102
  • [3] Nanoparticle Albumin-bound Paclitaxel (NabP) As A Single Agent For The Treatment Of Recurrent Stage 4 Non-small Cell Lung Cancer (NSCLC).
    Saxena, A.
    Christos, P. J.
    Cagney, J. M.
    Scheff, R. J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S310 - S311
  • [4] Retrospective analysis of nanoparticle albumin-bound paclitaxel (nabP) administered as a single agent in the treatment of recurrent stage IV (st4) non-small cell lung cancer (NSCLC).
    Saxena, Ashish
    Christos, Paul J.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Hannah A. Blair
    Emma D. Deeks
    [J]. Drugs, 2015, 75 : 2017 - 2024
  • [6] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Blair, Hannah A.
    Deeks, Emma D.
    [J]. DRUGS, 2015, 75 (17) : 2017 - 2024
  • [7] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Ashish Saxena
    Bryan J. Schneider
    Paul J. Christos
    Lauren F. Audibert
    Jennifer M. Cagney
    Ronald J. Scheff
    [J]. Medical Oncology, 2016, 33
  • [8] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Saxena, Ashish
    Schneider, Bryan J.
    Christos, Paul J.
    Audibert, Lauren F.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    [J]. MEDICAL ONCOLOGY, 2016, 33 (02) : 1 - 9
  • [9] Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer A retrospective analysis
    Naito, Yujiro
    Tamiya, Akihiro
    Tamiya, Motohiro
    Kimura, Yohei
    Hamaguchi, Masanari
    Saijo, Nobuhiko
    Kanazu, Masaki
    Tokura, Sayoko
    Shiroyama, Takayuki
    Morisita, Naoko
    Omachi, Naoki
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. MEDICINE, 2017, 96 (35)
  • [10] A retrospective study in Chinese patients: Is there a role of nanoparticle albumin bound paclitaxel in advanced NSCLC?
    Zhu, Y.
    Xing, P.
    Shan, L.
    Chen, S.
    Hao, X.
    Li, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345